Viewing data from:

CICLOPIROX

ANDA

CICLOPIROX | A076790 | SUN PHARMA CANADA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LOPROX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 3 NDCs

Highest NADAC/Unit

$0.2285

per gm

Lowest NADAC/Unit

$0.0998

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51672131801CICLOPIROX 0.77% CREAM	$0.2285	GM	Generic	—	2026-10-21
51672131802CICLOPIROX 0.77% CREAM	$0.1685	GM	Generic	—	2026-10-21
51672131808CICLOPIROX 0.77% CREAM	$0.0998	GM	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$12.25

Highest Price

$54.11

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51672-1318-01CICLOPIROX OLAMINE 0.77% CREAM,TOP	$12.25	FSS	AvKare, LLC	06/14/2028
51672-1318-02CICLOPIROX OLAMINE 0.77% CREAM,TOP	$22.59	FSS	AvKare, LLC	06/14/2028
51672-1318-08CICLOPIROX OLAMINE 0.77% CREAM,TOP	$54.11	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs4 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

OLON SPACICLOPIROX OLAMINE

DMF 113891995

KUMAR ORGANIC PRODUCTS LIMITEDCICLOPIROX OLAMINE

DMF 423042025

ERREGIERRE SPACICLOPIROX OLAMINE USP-PH.EUR.

DMF 163522003

ERREGIERRE SPACICLOPIROX USP-EP

DMF 163532002

PCASCICLOPIROX

DMF 170072003

OLON SPACICLOPIROX

DMF 171562004

INTERQUIM SACICLOPIROX USP

DMF 189292005

EUROAPI GERMANY GMBHInactiveCICLOPIROX

DMF 146271999

SANOFI AVENTIS DEUTSCHLAND GMBHInactiveCICLOPIROX OLAMINE

DMF 146331999

PIERRE FABRE MEDICAMENTInactiveCICLOPIROX

DMF 171992004

SYNKEM SASInactiveCICLOPIROX

DMF 173472004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.77%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Apr 12, 2005

No patent or exclusivity listings for this strength.